Utility of Heart Rate Variability in Cardiovascular Risk Assessment

Introduction to Heart Rate Variability

Heart rate variability (HRV) is a significant predictor of total mortality, but has limited utility specifically for sudden cardiac death (SCD) risk stratification, with its primary value being as an independent prognostic marker when combined with other cardiovascular risk factors, as noted by the American College of Cardiology 1, 2

Multiple studies show increased mortality in patients with low time and frequency domain measures of HRV, with relative risk typically in the range of 2-3, according to the American College of Cardiology 2
The ATRAMI study demonstrated that post-MI patients with low HRV had a relative mortality risk of 3.2, independent of left ventricular ejection fraction (LVEF) and ventricular ectopy, as reported by the European Society of Cardiology 3
HRV is generally a better predictor of total mortality than of sudden cardiac death specifically, as stated by the American College of Cardiology 2
When combined with other risk factors, particularly reduced LVEF (<35%), low HRV identifies patients at significantly higher risk, according to the European Heart Journal 4, 5

The utility of HRV for risk stratification in patients with dilated cardiomyopathy remains unclear, with conflicting evidence from major trials, as noted by the American College of Cardiology 6
In the DINAMIT trial, using low HRV to select post-MI patients with reduced LVEF for ICD implantation did not improve survival, as nonarrhythmic mortality increased in the ICD group, according to the American College of Cardiology 2
Short-term HRV has limited data linking it to sudden death, and its use for SCD risk stratification is not currently recommended, as stated by the American College of Cardiology 7

Time-domain measures (like SDNN <70 ms) and frequency-domain measures show approximately equivalent predictive ability for mortality, as reported by the American College of Cardiology and the European Heart Journal 2, 4
Of nonlinear methods, the power-law relationship has been studied most extensively, with some studies showing it may have better predictive value than time-domain measures, according to the American College of Cardiology 1, 2

The combination of low HRV and depressed baroreflex sensitivity (BRS) significantly increases risk; 1-year mortality increased from 1% when both markers were preserved to 15% when both were depressed, as reported by the European Heart Journal 4, 5
The association of LVEF <35% with low HRV further increases cardiovascular risk, according to the European Heart Journal 4
In patients over 65, HRV has higher prognostic value than BRS, as stated by the European Heart Journal 4
Heart rate turbulence (variability in cycle length after a spontaneous post-extrasystolic pause) represents another measure of vagal activity that may complement HRV assessment, as reported by the European Heart Journal 4, 5

The American College of Cardiology notes that autonomic nervous system fluctuations are the primary driver of HRV, with parasympathetic activity increasing overall variability while sympathetic activity acts as a low-pass filter 8
Higher psychological distress is consistently associated with reduced HRV, but studies examining psychological well-being in relation to HRV have found less consistent associations 8, 9, 10, 11

Low HRV is associated with metabolic syndrome prevalence and metabolic dysfunction, according to the American College of Cardiology 10, 11